Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Oct 31, 2022
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$0
Net Open-Market Flow
$19K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2022Buy(P)8K$0.42$3K12.0M
Oct 27, 2022Buy(P)23K$0.27$6K12.0M
Oct 26, 2022Buy(P)12K$0.27$3K11.9M
Oct 25, 2022Buy(P)20K$0.26$5K11.9M
Oct 24, 2022Buy(P)8K$0.22$2K11.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-054902) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML